The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Core outcome measures for interventions to prevent or slow the progress of dementia for people living with mild to moderate dementia: Systematic review and consensus recommendations
Open accessAbstract
BACKGROUND: There are no disease-modifying treatments for dementia. There is also no consensus on disease modifying outcomes. We aimed to produce the first evidence-based consensus on core outcome measures for trials of disease modification in mild-to-moderate dementia. METHODS AND FINDINGS: We defined disease-modification interventions as those aiming to change the underlying pathology. We systematically searched electronic databases and previous systematic reviews for published and ongoing trials of disease-modifying treatments in mild-to-moderate dementia. We included 149/22,918 of the references found; with 81 outcome measures from 125 trials. Trials involved participants with Alzheimer's disease (AD) alone (n = 111), or AD and mild cognitive impairment (n = 8) and three vascular dementia. We divided outcomes by the domain measured (cognition, activities of daily living, biological markers, neuropsychiatric symptoms, quality of life, global). We calculated the number of trials and of participants using each outcome. We detailed psychometric properties of each outcome. We sought the views of people living with dementia and family carers in three cities through Alzheimer's society focus groups. Attendees at a consensus conference (experts in dementia research, disease-modification and harmonisation measures) decided on the core set of outcomes using these results. Recommended core outcomes were cognition as the fundamental deficit in dementia and to indicate disease modification, serial structural MRIs. Cognition should be measured by Mini Mental State Examination or Alzheimer's Disease Assessment Scale-Cognitive Subscale. MRIs would be optional for patients. We also made recommendations for measuring important, but non-core domains which may not change despite disease modification. LIMITATIONS: Most trials were about AD. Specific instruments may be superseded. We searched one database for psychometric properties. INTERPRETATION: This is the first review to identify the 81 outcome measures the research community uses for disease-modifying trials in mild-to-moderate dementia. Our recommendations will facilitate designing, comparing and meta-analysing disease modification trials in mild-to-moderate dementia, increasing their value. TRIAL REGISTRATION: PROSPERO no. CRD42015027346.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · Brain and nerve · Cited by 21,038
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Older Adults' Reasons for Using Technology while Aging in Place
Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J. M., & Wouters, E. J. M. (2016) · Gerontology · doi:10.1159/000430949 · Cited by 19,690
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. (2015) · Gerontology · doi:10.1159/000362720 · Cited by 18,909
The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568
A New Clinical Scale for the Staging of Dementia
Hughes, C. P., Berg, L., Danziger, W., Coben, L. A., & Martin, R. L. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.140.6.566 · Cited by 7,056
A new rating scale for Alzheimer's disease
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.11.1356 · Cited by 4,175
Epidemiology and the web of causation: has anyone seen the spider?
Krieger, N. (1994) · Social Science & Medicine · doi:10.1016/0277-9536(94)90202-x · Cited by 1,731
National Institute for Health Research
Evans, R. (2014) · Nursing Standard · doi:10.7748/ns.28.49.32.s37 · Cited by 1,350
A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
Doody, R. S., Raman, R., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., Kieburtz, K., He, F., Sun, X., Thomas, R. G., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1210951 · Cited by 1,224
Gélinas, I., Gauthier, L., McIntyre, M., & Gauthier, S. (1999) · The American Journal of Occupational Therapy · doi:10.5014/ajot.53.5.471 · Cited by 900
Smith, S., Lamping, D., Banerjee, S., Harwood, R., Foley, B., Smith, P., Cook, J., Murray, J., Prince, M., Levin, E., et al. (2005) · Health Technology Assessment · doi:10.3310/hta9100 · Cited by 639
Self-citationEffects of Aβ immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease
Fox, N. C., Black, R. S., Gilman, S., Rossor, M. N., Griffith, S. G., Jenkins, L., & Koller, M. (2005) · Neurology · doi:10.1212/01.wnl.0000159743.08996.99 · Cited by 550
A European consensus on outcome measures for psychosocial intervention research in dementia care
Moniz-Cook, E., Vernooij-Dassen, M., Woods, R., Verhey, F., Chattat, R., Vugt, M. D., Mountain, G., O’connell, M., Harrison, J., Vasse, E., et al. (2008) · Aging & Mental Health · doi:10.1080/13607860801919850 · Cited by 391
Self-citationFerraz, M. C., de Oliveira, J. L., de Oliveira Junior, J. R., Cogo, J. C., dos Santos, M. G., Franco, L. M., Puebla, P., Ferraz, H. O., Ferraz, H. G., da Rocha, M. M. T., et al. (2015) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2015/939523 · Cited by 373
Gold, D. A. (2012) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2011.614598 · Cited by 371
Banerjee, S. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.072983 · Cited by 351
Self-citationBanerjee, S., Samsi, K., Petrie, C. D., Alvir, J., Treglia, M., Schwam, E. M., & del Valle, M. (2009) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2090 · Cited by 303
Self-citationSalmon, D. P., Thal, L. J., Butters, N., & Heindel, W. C. (1990) · Neurology · doi:10.1212/wnl.40.8.1225 · Cited by 274
The needs of older people with dementia in residential care
Hancock, G. A., Woods, B., Challis, D., & Orrell, M. (2006) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1421 · Cited by 269
Self-citationDuits, F. H., Martinez‐Lage, P., Paquet, C., Engelborghs, S., Lleó, A., Hausner, L., Molinuevo, J. L., Stomrud, E., Farotti, L., Ramakers, I. H. G. B., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.08.003 · Cited by 258
Why has therapy development for dementia failed in the last two decades?
Gauthier, S., Albert, M., Fox, N., Goedert, M., Kivipelto, M., Mestre‐Ferrandiz, J., & Middleton, L. T. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.12.003 · Cited by 238
Review of brief cognitive tests for patients with suspected dementia
Velayudhan, L., Ryu, S.-H., Raczek, M., Philpot, M., Lindesay, J., Critchfield, M., & Livingston, G. (2014) · International Psychogeriatrics · doi:10.1017/s1041610214000416 · Cited by 221
Self-citationSpalletta, G., Musicco, M., Padovani, A., Perri, R., Fadda, L., Canonico, V., Trequattrini, A., Pettenati, C., Caltagirone, C., Palmer, K., et al. (2010) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181d6b68d · Cited by 190
Clinical trial of an inhibitor of RAGE-Aβ interactions in Alzheimer disease
Galasko, D., Bell, J., Mancuso, J. Y., Kupiec, J. W., Sabbagh, M. N., van Dyck, C., Thomas, R. G., Aisen, P. S., & Study, F. T. A. D. C. (2014) · Neurology · doi:10.1212/wnl.0000000000000364 · Cited by 187
Determining the minimum clinically important differences for outcomes in the DOMINO trial
Howard, R., Phillips, P., Johnson, T., O'Brien, J., Sheehan, B., Lindesay, J., Bentham, P., Burns, A., Ballard, C., Holmes, C., et al. (2011) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2607 · Cited by 185
Self-citationEndpoints for trials in Alzheimer's disease: a European task force consensus
Vellas, B. J., Andrieu, S., Sampaio, C., Coley, N., & Wilcock, G. K. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70087-5 · Cited by 165
Mitchell, A. J. (2012) · Springer eBooks · doi:10.1007/978-1-4471-2452-8_2 · Cited by 163
Disease-modifying trials in Alzheimer's disease: a European task force consensus
Vellas, B. J., Andrieu, S., Sampaio, C., & Wilcock, G. K. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70677-9 · Cited by 157
Initiative, F. T. A. D. N., Skinner, J., Carvalho, J. O., Potter, G. G., Thames, A., Zelinski, E., Crane, P. K., & Gibbons, L. E. (2012) · Brain Imaging and Behavior · doi:10.1007/s11682-012-9166-3 · Cited by 151
What is the clinically relevant change on the ADAS-Cog?
Schrag, A., & Schott, J. (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-300881 · Cited by 149
The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer’s Disease
Deardorff, W. J., Feen, E. S., & Grossberg, G. T. (2015) · Drugs & Aging · doi:10.1007/s40266-015-0273-x · Cited by 147
Gauthier, S. G., Aisen, P. S. S., Ferris, S. H., Saumier, D., Duong, A., Haine, D., Garceau, D., Suhy, J., Oh, J., Lau, W. C., et al. (2009) · The journal of nutrition health & aging · doi:10.1007/s12603-009-0106-x · Cited by 139
Outcomes measures in a decade of dementia and mild cognitive impairment trials
Harrison, J. K., Noel-Storr, A. H., Demeyere, N., Reynish, E. L., & Quinn, T. J. (2016) · Alzheimer s Research & Therapy · doi:10.1186/s13195-016-0216-8 · Cited by 119
Matallana, D., de Santacruz, C., Cano, C. A., Reyes, P. A., Samper‐Ternent, R., Markides, K. S., Ottenbacher, K. J., & Ortiz, C. A. R. (2010) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988710373597 · Cited by 106
Cognitive Screening Instruments: A Practical Approach
Larner, A. J. (2012) · Springer eBooks · doi:10.1007/978-1-4471-2452-8 · Cited by 86
Apostolova, L. G., Zarow, C., Biado, K., Hurtz, S., Boccardi, M., Somme, J. H., Honarpisheh, H., Blanken, A. E., Brook, J. K., Tung, S., et al. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.01.001 · Cited by 85
Webster, L., Groskreutz, D., Grinbergs‐Saull, A., Howard, R. J., O'Brien, J. T., Mountain, G. A., Banerjee, S., Woods, B. T., Perneczky, R., Lafortune, L., et al. (2017) · Health Technology Assessment · doi:10.3310/hta21260 · Cited by 76
Self-citationThe Trajectory of Dementia in the UK - Making a DifferencePreprint
Lewis, F. I., Schaffer, S. K., Sussex, J., O'Neill, P. P., & Cockcroft, L. (2014) · RePEc: Research Papers in Economics · Cited by 72
024 What is the clinically relevant change on the ADAS-cog?
Schott, J. M., & Schrag, A. E. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301993.66 · Cited by 67
Rockwood, K. J., Fay, S., & Gorman, M. (2009) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2319 · Cited by 61
Mak, E., Su, L., Williams, G. B., Watson, R., Firbank, M., Blamire, A. M., & O'Brien, J. T. (2015) · NeuroImage: Clinical · doi:10.1016/j.nicl.2015.01.017 · Cited by 51
Self-citationAwareness of functional ability in people with early‐stage dementia
Martyr, A., & Clare, L. (2017) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4664 · Cited by 48
Self-citationBrookmeyer, R., Kawas, C. H., Abdallah, N., Paganini‐Hill, A., Kim, R. C., & Corrada, M. M. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.01.004 · Cited by 46
Neuroprotective Effects of Cistanches Herba Therapy on Patients with Moderate Alzheimer’s Disease
Li, N., Wang, J., Ma, J., Gu, Z., Jiang, C. Q., Yu, L., & Xiao-jie, F. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/103985 · Cited by 31
Zhou, B., Teramukai, S., Yoshimura, K., & Fukushima, M. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1124 · Cited by 25
Persistence of and Changes in Neuropsychiatric Symptoms in Alzheimer Disease Over 6 Months
Ryu, S.-H., Katona, C., Rive, B., & Livingston, G. (2005) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200511000-00008 · Cited by 22
Self-citationEmerging amyloid disease-modifying drugs for Alzheimer’s disease
Galimberti, D., & Scarpini, E. A. (2016) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2016.1146678 · Cited by 15
Banerjee, S. (2007) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2007.04.384 · Cited by 13
Self-citationRisk Factors for Post-Lumbar Puncture Headache in a Study of Alzheimer's Disease Biomarkers
Park, Y. H., Wang, M. J., Jang, J., Park, Y. H., Lee, J. W., & Kim, S. (2015) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2015.14.1.12 · Cited by 3
Cited by
Cognitive stimulation to improve cognitive functioning in people with dementia
Woods, B., Aguirre, E., Spector, A. E., & Orrell, M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005562.pub2 · Cited by 855
Self-citationLamb, S. E., Sheehan, B., Atherton, N., Nichols, V., Collins, H., Mistry, D., Dosanjh, S., Slowther, A. M., Khan, I., Petrou, S., et al. (2018) · BMJ · doi:10.1136/bmj.k1675 · Cited by 417
Self-citationAndrews, J. S., Desai, U., Kirson, N. Y., Zichlin, M. L., Ball, D. E., & Matthews, B. R. (2019) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2019.06.005 · Cited by 338
Collagen- and hyaluronic acid-based hydrogels and their biomedical applications
Xu, Q., Torres, J. E., Hakim, M., Babiak, P. M., Pal, P., Battistoni, C. M., Nguyen, M., Panitch, A., Solorio, L., & Liu, J. C. (2021) · Materials Science and Engineering: R: Reports · doi:10.1016/j.mser.2021.100641 · Cited by 318
Advanced maternal age and adverse pregnancy outcomes
Frick, A. P. (2021) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2020.07.005 · Cited by 304
Metadata
- Authors
- Webster, L., Groskreutz, D., Grinbergs-Saull, A., Howard, R., O’Brien, J. T., Mountain, G., Banerjee, S., Woods, B., Perneczky, R., Lafortune, L., Roberts, C., McCleery, J., Pickett, J., Bunn, F., Challis, D., Charlesworth, G., Featherstone, K., Fox, C., Goodman, C., Jones, R., Lamb, S., Moniz-Cook, E., Schneider, J., Shepperd, S., Surr, C., Thompson-Coon, J., Ballard, C., Brayne, C., Burns, A., Clare, L., Garrard, P., Kehoe, P., Passmore, P., Holmes, C., Maidment, I., Robinson, L., & Livingston, G.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-06-29
- Volume
- 12
- Issue
- 6
- Pages
- e0179521
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2732350692
- Cited by
- 415
- References
- 51
- FWCI
- 12.40
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.